300006.SZ
Chongqing Lummy Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 5.09
−3.42%Aug 10, 2026, 07:44 UTC
Lemei Pharmaceutical obtained the Drug Registration Certificate for Acetylcysteine Solution for Inhalation (3ml:0.3g) approved by the National Medical Products Administration, valid until August 3, 2031, for the treatment of respiratory diseases.
Jul 2, 2026, 07:45 UTC
Lummy Pharmaceutical's industrial investment fund Saifu Health plans to liquidate and dissolve.